查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1602357

痤疮治疗药物市场：按痤疮类型、药物类别、药物类型、给药途径分类 - 全球预测 2025-2030

Acne Drugs Market by Acne Type (Comedonal, Cystic, Inflammatory), Drug Class (Antibiotics, Combination Drugs, Hormonal Agents), Drug Type, Route of Administration - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年痤疮治疗市场价值为59.6亿美元，预计到2024年将达到63.2亿美元，复合年增长率为6.23%，预计到2030年将达到91亿美元。

痤疮治疗市场的范围包括开髮用于治疗痤疮的药物，痤疮是一种影响全球数百万人的常见皮肤病。这个市场包括非处方药和处方药，如类类视色素A、抗生素和荷尔蒙治疗。对痤疮药物的需求源于美学和健康问题，以解决身体不适和心理影响，如低自尊和社交焦虑。应用范围从外用乳膏到内服药物，用于治疗不同程度的痤疮严重程度。最终用途包括私人消费者、皮肤科诊所和医院。影响生长的因素包括皮肤健康意识的提高、皮肤病学研究的进步以及痤疮盛行率的上升，尤其是在青少年和成年人中。现代商机，例如对个人化医疗日益增长的兴趣以及向天然和有机产品的转变，正在为企业指明创新之路。公司可以透过投资个人化治疗解决方案的研发和扩大有机产品线来利用这些优势。然而，市场面临着限制和挑战，例如严格的监管监督、潜在的药物副作用以及来自雷射疗法等替代疗法的竞争。此外，围绕痤疮治疗药物的功效和安全性问题也是一个主要障碍。具有巨大潜力的创新领域包括基于生物技术的解决方案、微生物友善产品以及用于个人化治疗计划的人工智慧主导的诊断工具。该市场的特点是技术进步迅速，竞争公司之间竞争激烈。公司应专注于与皮肤科医生合作并投资消费者教育，以克服市场挑战并利用新趋势。此外，透过确保进行临床试验并保持产品功效的透明度，公司可以获得消费者的信任并扩大市场。

主要市场统计
基准年[2023] 59.6亿美元
预测年份 [2024] 63.2亿美元
预测年份 [2030] 91亿美元
复合年增长率（%） 6.23%

市场动态：揭示快速发展的痤疮治疗市场的关键市场洞察

供需的动态交互作用正在改变痤疮治疗市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球皮肤相关疾病的增加
    • 提高皮肤健康意识并专注于个人化治疗
    • 电子商务平台上痤疮治疗药物的供应不断增加
  • 市场限制因素
    • 护肤药物替代品增加
  • 市场机会
    • 介绍改良和增强的痤疮治疗方法
    • 联合治疗的需求不断增长
  • 市场挑战
    • 化妆品核准法规严格、流程复杂

波特的五力：驾驭痤疮治疗市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解痤疮治疗市场的外部影响

外部宏观环境因素在塑造痤疮治疗药物市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解痤疮治疗市场的竞争格局

对痤疮治疗药物市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 痤疮治疗药物市场供应商定位矩阵绩效评估

FPNV定位矩阵是评估痤疮治疗药物市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划痤疮治疗药物市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对痤疮治疗药物市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球皮肤相关疾病的发生率增加
      • 人们对皮肤健康的认识不断提高以及个人化治疗的趋势
      • 提高电子商务平台上痤疮治疗的可用性
    • 抑制因素
      • 护肤药物有很多替代品。
    • 机会
      • 介绍改良和增强的痤疮治疗方法
      • 联合治疗的需求不断增长
    • 任务
      • 化妆品药品核准监管严格、流程复杂
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章按痤疮类型分類的痤疮治疗药物市场

  • 粉刺性的
  • 囊状的
  • 发炎的
  • 手术后/伤口

第七章按药物类别分類的痤疮治疗药物市场

  • 抗生素
  • 伴随药物
  • 荷尔蒙药物
  • 类视色素A

第 8 章：按药物类型分類的痤疮治疗市场

  • 非处方药
  • 处方药

第九章痤疮治疗药物市场：依给药途径

  • 可注射的
  • 口服
  • 话题

第10章美洲痤疮治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区痤疮治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章：欧洲、中东和非洲的痤疮治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • Almirall, SA
  • Amgen, Inc.
  • Apotex Inc.
  • Arctic Therapeutics
  • Bausch Health Companies Inc.
  • Bayer AG
  • BioPharmX, Inc.
  • Cipher Pharmaceuticals Inc.
  • Daiichi Sankyo Company, Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • F. Hoffmann-La Roche AG
  • Galderma SA
  • Intas Pharmaceuticals Ltd.
  • Johnson & Johnson Services, Inc.
  • Mayne Pharma Group Limited
  • Midas Pharma GmbH
  • Mylan NV
  • Novartis AG
  • Pfizer Inc.
  • Skinvisible Pharmaceuticals, Inc.
  • Stiefel Laboratories, Inc. by GSK Group
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-434CCDA051B4

The Acne Drugs Market was valued at USD 5.96 billion in 2023, expected to reach USD 6.32 billion in 2024, and is projected to grow at a CAGR of 6.23%, to USD 9.10 billion by 2030.

The scope of the acne drugs market encompasses pharmaceutical products developed to treat acne, a common dermatological condition affecting millions globally. This market includes over-the-counter solutions and prescription medications such as retinoids, antibiotics, and hormonal treatments. The necessity of acne drugs arises from both cosmetic and health considerations, addressing physical discomfort and psychological impacts, such as diminished self-esteem and social anxiety. Applications extend from topical creams to oral medications, catering to various severity levels of acne. End-use includes individual consumers, dermatology clinics, and hospitals. Influencing growth factors include increasing awareness of skin health, advancements in dermatological research, and the rising prevalence of acne, particularly among adolescents and adults. The latest opportunities, such as the growing interest in personalized medicine and the shift towards natural and organic products, present avenues for businesses to innovate. Companies can capitalize on these by investing in R&D for personalized treatment solutions and expanding organic product lines. However, the market faces limitations and challenges like stringent regulatory scrutiny, potential side effects of drugs, and high competition from alternative treatments such as laser therapy. Moreover, the efficacy and safety concerns surrounding acne medications pose significant hurdles. Innovation areas with great potential include biotechnology-based solutions, microbiome-friendly products, and artificial intelligence-driven diagnostic tools for personalized treatment plans. The market is characterized by rapid technological advancements and intense competitive rivalry. Businesses should focus on collaboration with dermatologists and investing in consumer education to overcome market challenges and leverage emerging trends. Ensuring robust clinical trials and maintaining transparency in product efficacy can also instill consumer trust and expand market reach.

KEY MARKET STATISTICS
Base Year [2023] USD 5.96 billion
Estimated Year [2024] USD 6.32 billion
Forecast Year [2030] USD 9.10 billion
CAGR (%) 6.23%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Acne Drugs Market

The Acne Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidences of skin-related diseases in individuals worldwide
    • Growing awareness regarding skin health and inclination toward specific personalized treatments
    • Increasing availability of acne drugs on eCommerce platforms
  • Market Restraints
    • Availability of numerous alternatives for skin care drugs
  • Market Opportunities
    • Introduction of improved and enhanced acne drugs
    • Emerging demand for combination therapy
  • Market Challenges
    • Stringent regulations and complicated processes in the approval of cosmetic drugs

Porter's Five Forces: A Strategic Tool for Navigating the Acne Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Acne Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Acne Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Acne Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Acne Drugs Market

A detailed market share analysis in the Acne Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Acne Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Acne Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Acne Drugs Market

A strategic analysis of the Acne Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Acne Drugs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Almirall, S.A., Amgen, Inc., Apotex Inc., Arctic Therapeutics, Bausch Health Companies Inc., Bayer AG, BioPharmX, Inc., Cipher Pharmaceuticals Inc., Daiichi Sankyo Company, Ltd., Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche AG, Galderma S.A., Intas Pharmaceuticals Ltd., Johnson & Johnson Services, Inc., Mayne Pharma Group Limited, Midas Pharma GmbH, Mylan N.V, Novartis AG, Pfizer Inc., Skinvisible Pharmaceuticals, Inc., Stiefel Laboratories, Inc. by GSK Group, Sun Pharmaceutical Industries Limited, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Acne Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Acne Type, market is studied across Comedonal, Cystic, Inflammatory, and Postsurgical/Wound.
  • Based on Drug Class, market is studied across Antibiotics, Combination Drugs, Hormonal Agents, and Retinoids.
  • Based on Drug Type, market is studied across OTC Drugs and Prescription Drugs.
  • Based on Route of Administration, market is studied across Injectable, Oral, and Topical.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of skin-related diseases in individuals worldwide
      • 5.1.1.2. Growing awareness regarding skin health and inclination toward specific personalized treatments
      • 5.1.1.3. Increasing availability of acne drugs on eCommerce platforms
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of numerous alternatives for skin care drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of improved and enhanced acne drugs
      • 5.1.3.2. Emerging demand for combination therapy
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations and complicated processes in the approval of cosmetic drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Acne Drugs Market, by Acne Type

  • 6.1. Introduction
  • 6.2. Comedonal
  • 6.3. Cystic
  • 6.4. Inflammatory
  • 6.5. Postsurgical/Wound

7. Acne Drugs Market, by Drug Class

  • 7.1. Introduction
  • 7.2. Antibiotics
  • 7.3. Combination Drugs
  • 7.4. Hormonal Agents
  • 7.5. Retinoids

8. Acne Drugs Market, by Drug Type

  • 8.1. Introduction
  • 8.2. OTC Drugs
  • 8.3. Prescription Drugs

9. Acne Drugs Market, by Route of Administration

  • 9.1. Introduction
  • 9.2. Injectable
  • 9.3. Oral
  • 9.4. Topical

10. Americas Acne Drugs Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Acne Drugs Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Acne Drugs Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Almirall, S.A.
  • 3. Amgen, Inc.
  • 4. Apotex Inc.
  • 5. Arctic Therapeutics
  • 6. Bausch Health Companies Inc.
  • 7. Bayer AG
  • 8. BioPharmX, Inc.
  • 9. Cipher Pharmaceuticals Inc.
  • 10. Daiichi Sankyo Company, Ltd.
  • 11. Dr. Reddy's Laboratories Ltd.
  • 12. F. Hoffmann-La Roche AG
  • 13. Galderma S.A.
  • 14. Intas Pharmaceuticals Ltd.
  • 15. Johnson & Johnson Services, Inc.
  • 16. Mayne Pharma Group Limited
  • 17. Midas Pharma GmbH
  • 18. Mylan N.V
  • 19. Novartis AG
  • 20. Pfizer Inc.
  • 21. Skinvisible Pharmaceuticals, Inc.
  • 22. Stiefel Laboratories, Inc. by GSK Group
  • 23. Sun Pharmaceutical Industries Limited
  • 24. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. ACNE DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ACNE DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ACNE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ACNE DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ACNE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ACNE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ACNE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ACNE DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ACNE DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ACNE DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ACNE DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ACNE DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ACNE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ACNE DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ACNE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ACNE DRUGS MARKET DYNAMICS
  • TABLE 7. GLOBAL ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ACNE DRUGS MARKET SIZE, BY COMEDONAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ACNE DRUGS MARKET SIZE, BY CYSTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ACNE DRUGS MARKET SIZE, BY INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ACNE DRUGS MARKET SIZE, BY POSTSURGICAL/WOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ACNE DRUGS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ACNE DRUGS MARKET SIZE, BY COMBINATION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ACNE DRUGS MARKET SIZE, BY HORMONAL AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ACNE DRUGS MARKET SIZE, BY RETINOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ACNE DRUGS MARKET SIZE, BY OTC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ACNE DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ACNE DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ACNE DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ACNE DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ACNE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES ACNE DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 192. ACNE DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. ACNE DRUGS MARKET, FPNV POSITIONING MATRIX, 2023